Goldman Sachs: 2021 Vaccine Boost: While the uncertainty is elevated, our analysis suggests that the baseline outlook for vaccines is a positive one with significant vaccine distribution likely in the next 2-3 quarters and a likely sustained boost to growth next year. These findings support our above-consensus forecast for US and global GDP growth in 2021, despite challenging virus control today and slowing in several high-frequency indicators in the US.